Reboost Spray
FDA Recall NDC 62795-4005
FDA Enforcement Report: View Recall Date, Reasons, and Safety Status
Active & Historical Enforcement Reports
The FDA has identified 1 recorded enforcement report(s) associated with Reboost (NDC 62795-4005). A significant event, classified as Class I, was initiated on Dec 12, 2025 by Medinatura. The reported reason for this action was: "Microbial Contamination of Non-Sterile Products: The products have been found to contain yeast/mold and microbial contamination identified as Achromobacter."
This recall is currently ONGOING. Healthcare providers and patients are advised to check their inventory immediately against the affected codes provided below.
This recall is currently ONGOING. Healthcare providers and patients are advised to check their inventory immediately against the affected codes provided below.
Reported Recall Events
December 2025 Class I Recall: Microbial Contamination of Non-Sterile Products
Recall Number
Class I Ongoing
Microbial Contamination of Non-Sterile Products: The products have been found to contain yeast/mold and microbial contamination identified as Achromobacter.
Dec 12, 2025
Jan 14, 2026
N/A
Recall Profile & Regulatory Data
Event ID
98095
Classification
Class I
Enforcement Status
Ongoing
Recalling Firm
Medinatura New Mexico, inc.
Voluntary / Mandated
Voluntary: Firm initiated
Distribution Pattern
Nationwide in the US
Product Description
ReBoost Nasal Spray, 0.68 fl. oz. (20 mL) bottles, Distributed by: MediNatura, 10421 Research Rd., SE, Albuquerque, NM 87123, NDC 62795-4005-9, UPC 787647101863
Batch or Lot Expiration Information
Lot# All lots within expiry.
Affected Packages Involved in this Recall
62795-4005-9Product
7876471018Product
About FDA Recall Enforcement Reports
FDA recall data documents classified recall actions associated with a product. Most recalls are limited to specific lots, batches, or package configurations rather than every unit of a drug.
If a recall is listed for an NDC, review the affected lot information and package details carefully. Patients and healthcare professionals should confirm whether a specific product in hand matches the lot or package information before assuming it is affected.
